Positions
- Ruth Mitzner Professor in Neurosurgery
-
Neurosurgery
ÌÇÐÄlogo
Houston, TX, US
- Member
-
Dan L Duncan Comprehensive Cancer Center
ÌÇÐÄlogo
Houston, Texas, United States
- Professor (Joint Appointment)
-
Department of Otolaryngology – Head & Neck Surgery
ÌÇÐÄlogo
Houston, Texas, United States
- Residency Program Director
-
Neurosurgery
ÌÇÐÄlogo
Houston, Texas, United States
- Director of Brain Tumor Surgery
-
Neurosurgery
ÌÇÐÄlogo
Houston, Texas, United States
Addresses
- ÌÇÐÄlogo St. Luke's McNair Campus (Clinic)
-
7200 Cambridge
9th Floor
Houston, TX, 77030
United States
Phone: (713) 798-4696
- ÌÇÐÄlogo St. Luke's McNair Campus (Office)
-
7200 Cambridge
9th Floor
Houston, TX, 77030
United States
Phone: (713) 798-4696
Education
- BA from Rice University
- Houston, Texas, United States
- Biochemistry
- MD from ÌÇÐÄlogo
- Houston, Texas, United States
- Residency at ÌÇÐÄlogo
- Houston, Texas, United States
Certifications
- Diplomate
- American Board of Neurological Surgeons
Honors & Awards
- Educator of the Year (2021)
- Congress of Neurological Surgeons
- Christopher C. Getch Fellowship (2015)
- Congress of Neurological Surgeons
- Leadership Fellow, CNS Leadership Institute (2017)
- Congress of Neurological Surgeons
- Elected to the Society of Neurological Surgeons (2023)
- Society of Neurological Surgeons
- Vanguard Leadership in Health Care, CNS Leadership Institute (2026)
- Congress of Neurological Surgeons
- Elected to the American Academy of Neurological Surgery (2026)
- American Academy of Neurological Surgery
Professional Interests
- Open and endoscopic surgery for malignant and benign brain tumors
- Skull base tumors
- Meningiomas, acoustic neuromas, glioblastomas
- Brain tumor surgery in deep and eloquent brain regions
- Surgery and genetics of meningiomas and schwannomas
- Neurofibromatosis
Professional Statement
Dr. Patel is a board-certified neurosurgeon specializing in brain and skull base tumors, with particular expertise in meningiomas and vestibular schwannomas (acoustic neuromas). He provides individualized care through careful evaluation, advanced microsurgical techniques, and multidisciplinary collaboration. His NIH-funded laboratory studies the molecular biology of meningiomas to understand why they form, grow, and recur, with the goal of identifying new treatments.
Websites
Independent professional website of Dr. Patel, with clinical, research, and consultation information.
Publications and citations on Google Scholar.
Public bibliography of peer-reviewed publications.
Videos
Dr. Patel discusses collaboration in neurosurgery and how his laboratory uses machine learning and AI to study meningioma biology and molecular classification.
Selected Publications
-
Bayley JC V, Hadley CC, Harmanci AO, Harmanci AS, Klisch TJ, Patel AJ. " " Sci Adv. 2022 Feb 4; 8 (5)
Pubmed PMID: . -
Jackson HN, Hadley CC, Khan AB, Gadot R, Bayley JC V, Shetty A, Mandel J, Jalali A, Gallagher KK, Sweeney AD, Harmanci AO, Harmanci AS, Klisch TJ, Gopinath SP, Rao G, Yoshor D, Patel AJ. " " Neurosurgery. 2022 Jan 1; 90 (1) : 114-123.
Pubmed PMID: . -
Patel AJ, Wan YW, Al-Ouran R, Revelli JP, Cardenas MF, Oneissi M, Xi L, Jalali A, Magnotti JF, Muzny DM, Doddapaneni H, Sebastian S, Heck KA, Goodman JC, Gopinath SP, Liu Z, Rao G, Plon SE, Yoshor D, Wheeler DA, Zoghbi HY, Klisch TJ. " " Proc Natl Acad Sci U S A. 2019 Oct 22; 116 (43) : 21715-21726.
Pubmed PMID: . -
Patel AJ, Suki D, Hatiboglu M, Rao VY, Fox BD, Sawaya R. " " J Neurosurg. 2015 Mar 20; 1-12.
Pubmed PMID: .
Projects
- GammaTile Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms (GTM-101)
- GT Medical Technologies, Inc.
- ÌÇÐÄlogo, Houston, TX
- Site Principal Investigator, ÌÇÐÄlogo (2023-present). Multicenter observational study of GammaTile Surgically Targeted Radiation Therapy (STaRT) in intracranial brain neoplasms.
- ROADS: Post-Surgical Stereotactic Radiotherapy versus GammaTile for Newly Diagnosed Metastatic Brain Tumors (GTM-102)
- GT Medical Technologies, Inc.
- ÌÇÐÄlogo, Houston, TX
- Site Principal Investigator, ÌÇÐÄlogo (2024-2025). Phase 3 randomized controlled trial of post-surgical stereotactic radiotherapy (SRT) versus Surgically Targeted Radiation Therapy with GammaTile for newly diagnosed metastatic brain tumors.
- Single-Fraction versus Fractionated Post-Surgical Stereotactic Radiosurgery for Resected Brain Metastases (Alliance A071801)
- Alliance for Clinical Trials in Oncology
- ÌÇÐÄlogo, Houston, TX
- Site Principal Investigator, ÌÇÐÄlogo (2021-2022). Phase III trial comparing post-surgical single-fraction stereotactic radiosurgery (SRS) with fractionated SRS for resected metastatic brain disease.
Memberships
- Congress of Neurological Surgeons
- Executive Committee; 2027 Annual Meeting Chair; Education Committee Chair & Senior Advisor (01/2007)
- American Association of Neurological Surgeons
- Fellow (01/2007)
- Texas Association of Neurological Surgeons
- Vice President (01/2008)
- North American Skull Base Society
- Member (01/2017)
- American Academy of Neurological Surgery
- Member
- Society of Neurological Surgeons
- Executive Council; Chair, Medical Student Committee
- American Association of South Asian Neurosurgeons
- Secretary
- AANS/CNS Section on Tumors
- Executive Committee; Education Subcommittee
Funding
-
Establishing the Genomic Landscape of Human Atypical Meningiomas
#K08NS102474 - (07/01/2017 - 06/30/2022)
- Grant funding from NIH
-
Understanding the Epigenetic Drivers of Gene Expression Subtypes of Human Meningiomas
#19RDM005 - (11/01/2019 - 12/01/2020)
- Grant funding from Roderick D. MacDonald Research Grant
-
Establishing the Genomic Landscape of Human Atypical Meningiomas
#16RDM004 - (01/01/2017 - 12/31/2017)
- Grant funding from Roderick D. MacDonald Research Grant
-
Decoding Cellular Heterogeneity of Malignant Glioma
#5-RP160192 - (07/01/2015 - 06/01/2018)
- Grant funding from Cancer Prevention & Research Institute of Texas
-
Identifying the Biological Determinants of Aggressive Meningioma
#RP240263 - Grant funding from Cancer Prevention & Research Institute of Texas (CPRIT)
- Principal Investigator (2024-2027)
-
Harnessing Anti-Meningioma Immunity
#NW 73990-I - Grant funding from Helis Medical Research Foundation
- Co-Principal Investigator (2024-2027)
-
Genomic and Biochemical Mechanisms Underlying Meningioma Race Disparity Across Social and Structural Drivers of Health
#1U54CA302452-01 - Grant funding from National Cancer Institute (NCI)
- Co-Investigator (PI: David Raleigh) (2025-2030)
Intellectual Property
- Systems and Methods for Identifying Molecular Groups of Meningioma Using Radiographic and Radiomic Features
- Method Patent (Pending)
- Patent application filed June 2024.
- Co Inventors: Tiemo Klisch
Languages
Gujarati
to edit your profile